A detailed history of Integrated Wealth Concepts LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 33,027 shares of NVO stock, worth $2.91 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
33,027
Previous 32,550 1.47%
Holding current value
$2.91 Million
Previous $4.65 Million 15.37%
% of portfolio
0.05%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $56,796 - $69,365
477 Added 1.47%
33,027 $3.93 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $92,891 - $111,210
-757 Reduced 2.27%
32,550 $4.65 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $874,980 - $1.16 Million
8,569 Added 34.64%
33,307 $4.28 Million
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $52,931 - $63,586
-603 Reduced 2.38%
24,738 $2.56 Million
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $1.49 Million - $3.26 Million
16,336 Added 181.41%
25,341 $2.3 Million
Q2 2023

Aug 15, 2023

BUY
$155.98 - $172.65 $378,719 - $419,194
2,428 Added 36.92%
9,005 $1.46 Million
Q1 2023

May 03, 2023

SELL
$132.34 - $159.14 $2.86 Million - $3.43 Million
-21,577 Reduced 76.64%
6,577 $1.05 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $34,559 - $45,606
337 Added 1.21%
28,154 $3.81 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $31,347 - $38,469
329 Added 1.2%
27,817 $2.77 Million
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $89,302 - $105,365
865 Added 3.25%
27,488 $3.06 Million
Q1 2022

May 12, 2022

BUY
$93.1 - $112.54 $139,184 - $168,247
1,495 Added 5.95%
26,623 $2.96 Million
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $206,046 - $251,604
2,149 Added 9.35%
25,128 $2.81 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $77,581 - $97,983
919 Added 4.17%
22,979 $2.21 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $130,651 - $163,671
1,931 Added 9.59%
22,060 $1.85 Million
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $110,112 - $124,496
1,642 Added 8.88%
20,129 $1.36 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $108,037 - $124,795
1,691 Added 10.07%
18,487 $1.29 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $16,941 - $18,678
-266 Reduced 1.56%
16,796 $1.17 Million
Q2 2020

Jul 30, 2020

BUY
$58.54 - $67.94 $113,450 - $131,667
1,938 Added 12.81%
17,062 $1.12 Million
Q1 2020

May 18, 2020

BUY
$49.46 - $64.78 $44,019 - $57,654
890 Added 6.25%
15,124 $910,000
Q4 2019

Feb 20, 2020

BUY
$49.86 - $58.26 $239,826 - $280,230
4,810 Added 51.04%
14,234 $824,000
Q3 2019

Nov 15, 2019

BUY
$47.54 - $53.43 $178,179 - $200,255
3,748 Added 66.03%
9,424 $487,000
Q2 2019

Aug 15, 2019

BUY
$46.79 - $52.47 $265,580 - $297,819
5,676 New
5,676 $293,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.